| Literature DB >> 29709962 |
Keisuke Kasuga1, Minako Sako1, Shogo Kasai1, Hiroshi Yoshimoto1, Kuniko Iihara2, Hideaki Miura1.
Abstract
We herein report the case of a 61-year-old Japanese cirrhotic patient who developed rat bite fever (RBF) and whose first presentation was serious clinical features mimicking those of Henoch-Schönlein purpura (HSP). In addition to the critical clinical conditions, since the histopathology from purpuric skin eruptions was not inconsistent with that of HSP, therapy with prednisolone was promptly started in order to prevent his death. However, initial blood culture on admission yielded a small and slow-growing bacterial growth, which was gradually revealed by further subculture to be a peculiar bacterium, Streptobacillus moniliformis, leading to a definitive diagnosis of RBF. After the immediate cessation of prednisolone, the patient was treated with a more appropriate antibiotic and consequently made a full recovery. An immunocompromised condition with seriously decompensated liver cirrhosis together with moderately severe chronic kidney disease (CKD) in this patient probably exacerbated the severity of the disease.Entities:
Keywords: Henoch-Schönlein purpura (HSP); Streptobacillus moniliformis; chronic kidney disease (CKD); liver cirrhosis (LC); rat bite fever (RBF)
Mesh:
Substances:
Year: 2018 PMID: 29709962 PMCID: PMC6172531 DOI: 10.2169/internalmedicine.9856-17
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271
Figure 1.Dusky-red purpuric skin eruptions were obvious over the patient’s palms (a) and soles (b).
Laboratory Data on Admission.
| Hematology | Biochemistry | Immunology | Urinalysis | ||||||||||||||
| WBC | 7,420 | /μL | TP | 6.6 | g/dL | IgG | 2,079 | mg/dL | pH | 5.5 | |||||||
| Neu | 97.2 | % | Alb | 1.8 | g/dL | IgA | 553 | mg/dL | SG | 1.011 | |||||||
| RBC | 267×104 | /μL | AST | 79 | IU/L | IgM | 122 | mg/dL | WBC | 3+ | |||||||
| Hb | 8.8 | g/dL | ALT | 30 | IU/L | C3 | 42 | mg/dL | Nit | - | |||||||
| Hct | 25.7 | % | LDH | 259 | IU/L | C4 | 5 | mg/dL | Pro | 2+ | |||||||
| Plt | 3.8×104 | /μL | ALP | 328 | IU/L | CH50 | <12.0 | U/mL | Glu | - | |||||||
| T-Bil | 1.9 | mg/dL | C-ANCA | <1.0 | U/mL | Ket | - | ||||||||||
| Coagulation | D-Bil | 1.1 | mg/dL | P-ANCA | <1.0 | U/mL | Bil | - | |||||||||
| PT | 40 | % | AMY | 78 | IU/L | Autoantibody | <40 | ||||||||||
| PT-INR | 1.61 | BUN | 67 | mg/dL | RBC | 50-99 /HPF | |||||||||||
| APTT | 35.1 | s | Cre | 4.1 | g/dL | WBC | 10-19 /HPF | ||||||||||
| NH3 | 111 | μg/dL | |||||||||||||||
| FBG | 101 | mg/dL | |||||||||||||||
| CRP | 13.1 | mg/dL | |||||||||||||||
WBC: white blood cell, Neu: neutrophil, RBC: red blood cell, Hb: hemoglobin, Plt: platelet, PT: prothrombin time activity, PT-INR: prothrombin time activity-international normalized ratio, APTT: activated partial thromboplastin time, TP: total protein, Alb: albumin, AST: aspartate aminotransferase, ALT: alanine aminotransferase, LDH: lactate dehydrogenase, ALP: alkaline phosphatase, T-Bil: total bilirubin, D-Bil: direct bilirubin, AMY: amylase, BUN: blood urea nitrogen, Cre: creatinine, FBG: fasting blood glucose, CRP: C-reactive protein, C-ANCA: cytoplasic anti-neutrophil cytoplasmic antibody, P-ANCA: perinuclear anti-neutrophil cytoplasmic antibody, SG: specific gravity, Nit: Nitrile salt, Pro: protein, Glu: glucose, Ket: Ketone, Bil: bilirubin
Figure 2.Histopathological findings of a specimen obtained from eruptions on the left knee demonstrated unspecific vasculitis; extravasation of neutrophils and leukocytoclastic vasculitis were noted throughout the dermis (a, b). (a) Hematoxylin and Eosin (H&E) staining 40×, (b) H&E staining 400×.
Figure 3.Small and slow-growing bacteria were detected in the anaerobic culture bottle after 33 h of incubation (a). Gram stain (1,000×). After further subculture by exchanging media, some colonies were visualized on blood agar (b). On the sixth hospital day, highly pleomorphic filamentous Gram-negative bacilli were isolated (c). Gram stain (1,000×).
Antimicrobial susceptibility for Streptobacillus moniliformis.
| antimicrobial agent | MIC (μg/mL) | |||
|---|---|---|---|---|
| ABPC | Ampicillin | ≤0.12 | ||
| S/A | Sulbactam/Ampicillin | ≤0.5 | ||
| CEZ | Cefazolin | ≤0.5 | ||
| CTM | Cefotiam | ≤0.5 | ||
| FMOX | Flomoxef | ≤0.5 | ||
| CMZ | Cefmetazole | ≤0.5 | ||
| CPR | Cefpirome | ≤0.5 | ||
| PAPM | Panipenem/Betamipron | ≤0.12 | ||
| LVFX | Levofloxacin | ≤0.5 | ||
| MINO | Minocycline | ≤1 | ||
| CLDM | Clindamycin | ≤0.25 | ||
| ABK | Arbekacin | 16 | ||
| GM | Gentamicin | 4 | ||
| EM | Erythromycin | 4 | ||
| VCM | Vancomycin | ≤0.5 | ||
| TEIC | Teicoplanin | ≤0.5 | ||
MIC: minimum inhibitory concentration
Figure 4.The clinical course in the present case. PSL: prednisolone, CRP: C-reactive protein, Cre: creatinine
Figure 5.The underlined nucleotide sequence was identical to that of the R. rattus-derived strain.